Association of IDH1 mutation with survival of glioma patients in Indonesia

被引：0
|
作者：
Malueka, R. G. [1 ]
Dwianingsih, E. K. [2 ]
Bayuangga, H. F. [1 ]
Argo, I. W. [1 ]
Donurizki, A. D. [1 ]
Shaleh, S. [1 ]
Wicaksono, A. S. [3 ]
Dananjoyo, K. [1 ]
Asmedi, A. [1 ]
Hartanto, R. A. [3 ]
机构：
[1] Nursing Univ Gadjah Mada, Publ Hlth, Dept Neurol, Fac Med, Yogyakarta, Indonesia
[2] Nursing Univ Gadjah Mada, Publ Hlth, Dept Anat Pathol, Fac Med, Yogyakarta, Indonesia
[3] Nursing Univ Gadjah Mada, Publ Hlth, Fac Med, Div Neurosurg,Dept Surg, Yogyakarta, Indonesia
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2019年 / 405卷
关键词：
D O I：
10.1016/j.jns.2019.10.408
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WCN19-1497
引用
收藏
页数：1
相关论文
共 50 条
  • [21] IDH1 mutation analysis – an example of putative glioma marker
    Marzena Lewandowska
    T Szylberg
    K Roszkowski
    J Furtak
    W Windorbska
    J Rytlewska
    W Jóźwicki
    Hereditary Cancer in Clinical Practice, 10 (Suppl 3)
  • [22] An operative case of brain stem glioma with IDH1 mutation
    Matsuda, Kenichiro
    Kawanami, Kanako
    Sakurada, Kaori
    Oe, Rintaro
    Yamakawa, Mitsunori
    Sonoda, Yukihiko
    BRAIN PATHOLOGY, 2019, 29 : 150 - 150
  • [23] The IDH1 mutation as a potential target for immunotherapy of malignant glioma
    Schumacher, Theresa
    Sahm, Felix
    Pusch, Stefan
    von Deimling, Andreas
    Wick, Wolfgang
    Platten, Michael
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 165 - 165
  • [24] IDH1 mutation in chondrosarcoma and glioma of a patient with Ollier disease
    Theeler, B.
    Ragunathan, A.
    Aldape, K. D.
    Tremont-Lukats, I.
    JOURNAL OF NEUROLOGY, 2013, 260 : S25 - S25
  • [25] IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
    Sevin Turcan
    Daniel Rohle
    Anuj Goenka
    Logan A. Walsh
    Fang Fang
    Emrullah Yilmaz
    Carl Campos
    Armida W. M. Fabius
    Chao Lu
    Patrick S. Ward
    Craig B. Thompson
    Andrew Kaufman
    Olga Guryanova
    Ross Levine
    Adriana Heguy
    Agnes Viale
    Luc G. T. Morris
    Jason T. Huse
    Ingo K. Mellinghoff
    Timothy A. Chan
    Nature, 2012, 483 : 479 - 483
  • [26] IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
    Turcan, Sevin
    Rohle, Daniel
    Goenka, Anuj
    Walsh, Logan A.
    Fang, Fang
    Yilmaz, Emrullah
    Campos, Carl
    Fabius, Armida W. M.
    Lu, Chao
    Ward, Patrick S.
    Thompson, Craig B.
    Kaufman, Andrew
    Guryanova, Olga
    Levine, Ross
    Heguy, Adriana
    Viale, Agnes
    Morris, Luc G. T.
    Huse, Jason T.
    Mellinghoff, Ingo K.
    Chan, Timothy A.
    NATURE, 2012, 483 (7390) : 479 - U137
  • [27] IDH1 mutation detection by droplet digital PCR in glioma
    Wang, Jing
    Zhao, Yi-ying
    Li, Jian-feng
    Guo, Cheng-cheng
    Chen, Fu-rong
    Su, Hong-kai
    Zhao, Hua-fu
    Long, Ya-kang
    Shao, Jian-yong
    To, Shing-shun Tony
    Chen, Zhong-ping
    ONCOTARGET, 2015, 6 (37) : 39651 - 39660
  • [28] Correlation between grading and IDH1 mutation in Indonesian glioma
    Dwianingsih, E. K.
    Surename, F. No
    Bawono, R. G.
    Rhamadianti, A. F.
    Bayuangga, H. F.
    Malueka, R. G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 386 - 387
  • [29] IDH1/IDH2 mutations predict survival in glioma and AML
    Hegi, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S2 - S2
  • [30] An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients
    Lewandowska, Marzena Anna
    Furtak, Jacek
    Szylberg, Tadeusz
    Roszkowski, Krzysztof
    Windorbska, Wieslawa
    Rytlewska, Joanna
    Jozwicki, Wojciech
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (01) : 45 - 53
12345